The collaboration comes at a time when access to high-quality fertility treatment remains uneven, despite rapid market expansion
The expanded approval covers children and teens with chronic conditions that increase vulnerability to pneumococcal infections
Strategic collaboration aims to strengthen clinical capabilities, enhance patient experience and improve fertility treatment outcomes through scientific expertise, technology and data-driven care
Clara Sattler de Sousa e Brito to lead discovery solutions from Q3 2026, while Robert Machinek takes over as Head of Strategy & Business Development
The collaboration will foster joint research initiatives, scientific knowledge exchange, and innovation
An exploratory overall survival signal also leaned in favor of the combination, though the companies noted the result remains preliminary
The designation marks the first Breakthrough Therapy recognition for calderasib and is backed by positive results from the Phase 1 KANDLELIT-001 clinical trial
The decision now moves to the European Commission, with a final ruling expected by the third quarter of 2026
The trial will assess Precem-TcT, both as monotherapy and in combination with bevacizumab, in patients whose disease has progressed after or become resistant to standard treatments
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
